Table 1.
Patient demographic and clinical characteristics
Characteristic | UUI/OAB (n = 53) | Non-UUI/OAB (n = 47) | Total (N = 100) |
---|---|---|---|
Mean age (±SD) | 54.6 (±11.6) | 40.4 (±14.3) | 47.9 (±14.7) |
Gender, n (%) | |||
Female | 53 (100.0) | 47 (100.0) | 100 (100.0) |
Racial background, n (%) | |||
White | 38 (71.7) | 33 (70.2) | 71 (71.0) |
Black or African–American | 9 (17.0) | 10 (21.3) | 19 (19.0) |
Employment status, n (%) | |||
Full-time work | 30 (56.6) | 26 (55.3) | 56 (56.0) |
Part-time work | 10 (18.9) | 11 (23.4) | 21 (21.0) |
Retired | 8 (15.1) | 4 (8.5) | 12 (12.0) |
Education level, n (%) | |||
Secondary/high school | 9 (17.0) | 10 (21.3) | 19 (19.0) |
Some college education | 19 (35.8) | 11 (23.4) | 30 (30.0) |
College degree | 5 (9.4) | 6 (12.8) | 11 (11.0) |
Postgraduate education | 16 (30.2) | 18 (38.3) | 34 (34.0) |
Comorbid conditions, n (%) | |||
High blood pressure (hypertension) | 19 (35.8) | 8 (17.0) | 27 (27.0) |
High cholesterol | 15 (28.3) | 3 (6.4) | 18 (18.0) |
Anxiety | 10 (18.9) | 6 (12.8) | 16 (16.0) |
Depression | 12 (22.6) | 2 (4.3) | 14 (14.0) |
Current bladder medication, n (%) | |||
None | 41 (77.4) | 47 (100.0) | 88 (88.0) |
Solifenacin succinate (VESIcare®) | 4 (7.5) | 0 | 4 (4.0) |
Mean BMI, kg/m2 (±SD) | 31.1 (±6.6) | 26.4 (±5.0) | 28.9 (±6.3) |
BMI body mass index, OAB overactive bladder, UUI urgency urinary incontinence